PolyVascular

PolyVascular Inc. is a medical technology company based in Houston, Texas, dedicated to improving care for children with congenital heart defects (CHD). The company specializes in innovative, minimally invasive transcatheter heart valves that aim to reduce the need for repeated open-heart surgeries. Founded to address the challenges of current treatments for pediatric CHD, PolyVascular develops biocompatible, polymer-based pulmonary valves that grow with the child.

The company's core product is the only non-surgical transcatheter pulmonary valve and delivery system approved for children as young as 2 years old. This system is designed to be deployed percutaneously, avoiding the need for open-heart procedures. PolyVascular's technology offers durability and biocompatibility, addressing issues associated with animal-sourced valves and human donor grafts. The company is committed to transforming CHD care and improving the quality of life for young patients, with a goal of reaching 1 million pediatric patients worldwide.